Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chongqing Zhifei Biological Products Co. Ltd.

http://www.zhifeishengwu.com

Latest From Chongqing Zhifei Biological Products Co. Ltd.

VBP Pains Swell Prompting New China Strategy, Local Innovation Focus

As the rollout of volume-based procurement to more products brings more pain, drug makers are exploring different China strategies. One indicator, though, is clear - local innovation and distribution can’t be ignored anymore.

China Commercial

Watch Out GSK! China’s Homegrown Shingles Vaccine Set To Soar

Although the domestic developer did not provide sales figures for 2023, a new homegrown shingles vaccine in China is poised to eat into the market share of GSK’s Shingrix in the country.

China Vaccines

Pfizer Divests Select China Prevenar 13 Rights, Staff As Domestic Firms Gain Traction

Following in the steps of Merck & Co. and GSK, Pfizer is turning to a Chinese partner to more broadly market one of its top vaccines in the country - but the US firm is going one step further.

China Vaccines

Slashed Activities, Reduced Sales: Commercial Crackdown Dents Drug Makers In China

Among multinationals, AstraZeneca has reported its commercial activities have been negatively impacted by China's broad anti-corruption campaign, while J&J has seen some affect from the country's volume-based procurement scheme. Roche, Lilly and Novartis have also reported some softness in the last quarter versus the previous three months.

China Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Other Names / Subsidiaries
    • Beijing Luzhu Biopharmaceutical Co., Ltd.
UsernamePublicRestriction

Register